-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tazarotene in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tazarotene in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tazarotene in Idiopathic Pulmonary Fibrosis Drug Details: GRI-0621 is under...
-
Product Insights
Zentral Imm Boden – Level KS 1 Residential Tower – Styria
The Zentral Imm Boden – Level KS 1 Residential Tower – Styria involves the construction of the Level KS 1 Residential Tower in Gries District, Graz City, Styria State, Austria. Equip yourself with the essential tools needed to make informed and profitable decisions with our Zentral Imm Boden – Level KS 1 Residential Tower – Styria report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days...
-
Product Insights
Gries
Gries is an onshore wind project located in Valais, Switzerland. The project is owned by Grieswind AG and was developed by SwissWinds Development GmbH. The project came online in 2011. Empower your strategies with our Gries report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
Prado Gris Solar PV Park
Prado Gris Solar PV Park is a solar PV project located in Castile-La Mancha, Spain. The project is owned and being developed by Solarcentury Holdings Ltd. The project is at the permitting stage. Empower your strategies with our Prado Gris Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Primary Sclerosing Cholangitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Sclerosing Cholangitis - Drugs In Development, 2023’, provides an overview of the Primary Sclerosing Cholangitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Sclerosing Cholangitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Cholangitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cholangitis - Drugs In Development, 2023’, provides an overview of the Cholangitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cholangitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Attention Deficit Hyperactivity Disorder (ADHD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Drugs In Development, 2023’, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Mulilo De Aar Solar PV Park
Mulilo De Aar Solar PV Park is a solar PV project located in Northern Cape, South Africa. The project is owned by GRI Renewable Industries SL; Mulilo Renewable Energy (Pty) Ltd and was developed by GRI Renewable Industries SL; Mulilo Renewable Energy (Pty) Ltd; X-ELIO Energy SL. The project came online in 2014. Empower your strategies with our Mulilo De Aar Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be...
-
Product Insights
Serra Santana II
Serra Santana II is an Onshore Wind project located in Rio Grande do Norte, Brazil. The project is owned by Echoenergia Participacoes SA and was developed by GRI Renewable Industries SL. The project came online in 2015. Empower your strategies with our Serra Santana II report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
Serra Santana III
Serra Santana III is an Onshore Wind project located in Rio Grande do Norte, Brazil. The project is owned by Echoenergia Participacoes SA and was developed by GRI Renewable Industries SL. The project came online in 2015. Empower your strategies with our Serra Santana III report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...